AI in biotech: Fashioning the future of R&D and IP
In today’s dynamic biotech and biomedicine sectors, the transformative power of artificial intelligence (AI) stands at the forefront in R&D. To leverage AI to its full potential, it’s key to understand the nuanced, strategic advancements it brings –...
BioLizard joins Da’s Geniaal consortium
Ghent, October 24th, 2023. We are happy to announce that BioLizard has joined the Da’s Geniaal consortium. The Da’s Geniaal consortium aims to inspire youngsters between 10 and 14 years to take on more science and technology oriented studies, with a...
New LLM-based applications developed at the BioLizard Innovation Hackathon
Ghent, 18th September 2023. The first BioLizard Innovation Hackathon, on 14th September, was a resounding success. Four teams of our expert “Lizards” took 24 hours to develop applications that use the power of chatbots based on large language models (LLMs) to tackle...
Vibrant healthtech cluster of Ghent – including BioLizard – featured in Labiotech
Ghent, 14th September 2023. We are proud to part of the thriving community of life sciences, medtech, and digitech experts within the healthcare cluster of Ghent. This flourishing ecosystem has been featured in an article in Labiotech, which highlights the...